In the BioHarmony Drug Report Database

"Preview" Icon

Zonisamide

Zonegran (zonisamide) is a small molecule pharmaceutical. Zonisamide was first approved as Zonegran on 2000-03-27. It is used to treat epilepsy and partial epilepsies in the USA. It has been approved in Europe to treat epilepsy and partial epilepsies. It is known to target carbonic anhydrase 7, carbonic anhydrase 12, and carbonic anhydrase 1.

 

Trade Name

 

Zonegran
 

Common Name

 

zonisamide
 

ChEMBL ID

 

CHEMBL750
 

Indication

 

epilepsy, partial epilepsies
 

Drug Class

 

Image (chem structure or protein)

Zonisamide structure rendering